Objective-In resistance arteries, there is an emerging view that smooth muscle Ca V 3.2 channels restrain arterial constriction through a feedback response involving the large-conductance Ca 2+ -activated K + channel (BK Ca ). Here, we used wild-type and Ca V 3.2 knockout (Ca V 3.2 −/− ) mice to definitively test whether Ca V 3.2 moderates myogenic tone in mesenteric arteries via the Ca V 3.2-ryanodine receptor-BK Ca axis and whether this regulatory mechanism influences blood pressure regulation. Approach and Results-Using pressurized vessel myography, Ca V 3.2 −/− mesenteric arteries displayed enhanced myogenic constriction to pressure but similar K + -induced vasoconstriction compared with wild-type C57BL/6 arteries. Electrophysiological and myography experiments subsequently confirmed the inability of micromolar Ni 2+ , a Ca V 3.2 blocker, to either constrict arteries or suppress T-type currents in Ca V 3.2 −/− smooth muscle cells. The frequency of BK Cainduced spontaneous transient outward K + currents dropped in wild-type but not in knockout arterial smooth muscle cells upon the pharmacological suppression of Ca V 3.2 channel. Line scan analysis performed on en face arteries loaded with Fluo-4 revealed the presence of Ca 2+ sparks in all arteries, with the subsequent application of Ni 2+ only affecting wild-type arteries. Although Ca V 3.2 channel moderated myogenic constriction of resistance arteries, the blood pressure measurements of Ca V 3.2 −/− and wild-type animals were similar. Conclusions-Overall, our findings establish a negative feedback mechanism of the myogenic response in which Ca V 3.2 channel modulates downstream ryanodine receptor-BK Ca to hyperpolarize and relax arteries. (Arterioscler Thromb Vasc The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
T he cardiovascular system comprises a muscular pump and a distribution network of arteries, veins, and capillaries. Within this integrated system, resistance arteries control the magnitude and distribution of tissue perfusion and respond to vasoactive stimuli, including mechanical forces, neurotransmitters, and metabolites. [1] [2] [3] [4] [5] Bayliss first described the inherent ability of resistance arteries to constrict to elevated pressure, 6 and studies have shown that the so-called myogenic response is intimately tied to depolarization and the activation of smooth muscle L-type Ca 2+ channels. It is often presumed that Ca V 1.2 is the only Ca 2+ channel of functional significance because dihydropyridines, L-type blockers, prominently attenuate myogenic tone. 3 This traditional perspective has begun to change with the identification of arterial T-type Ca 2+ channels, including Ca V 3.1 and Ca V 3.2 subtypes. 7, 8 Recent findings suggest that the former (ie, Ca V 3.1) modestly facilitates myogenic constriction at hyperpolarized voltages, whereas the latter (ie, Ca V 3.2) facilitates a negative feedback response restraining arterial constriction. 9, 10 Our recent observations have tied the paradoxical ability of rat cerebral arterial Ca V 3.2 channel to limit myogenic tone to the triggering of ryanodine receptors (RyR) on the sarcoplasmic reticulum. The RyR-mediated generation of Ca 2+ sparks subsequently activates the large conductance Ca 2+ -activated K + channels (BK Ca ), eliciting a hyperpolarization to counteract pressure-induced constriction. 10 Furthermore, the Ca V 3.2 conductance in the human cerebral circulation seems to mediate a similar physiological role. 10 Although the concept of a voltage-gated Ca 2+ channel counterbalancing vasoconstriction is novel and intriguing, it is one delimited by 2 primary concerns. First, current work is heavily reliant on the presumed selectivity of Ni 2+ to block Ca V 3.2 channels. 11 Second, there is a lack of corroborative observations, outside the cerebral circulation, in vascular beds known to acutely and sustainably regulate systemic blood pressure.
Here, we used wild-type and Ca V 3.2 knockout (Ca V 3.2 −/− ) mice to definitively test whether Ca V 3.2 channel moderates myogenic tone in mesenteric arteries via the Ca V 3.2-RyR-BK Ca axis and, more generally, whether this regulatory mechanism influences blood pressure regulation. Experiments ranged from cells to whole animals and encompassed the integrative use of myography, electrophysiology, Ca 2+ imaging, and intravascular catheterization. Arteries displayed enhanced myogenic tone when Ca V 3.2 channels were genetically ablated or pharmacologically suppressed using Ni 2+ . Subsequent analyses indicated that Ni 2+ inhibited BK Ca currents and Ca 2+ sparks in wild-type but not Ca V 3.2 −/− arteries. Although Ca V 3.2 channel moderated myogenic constriction, the blood pressure measurements of both animal types were similar. In conclusion, this study establishes a negative feedback response in which Ca V 3.2 channel modulates downstream activity of the RyR-BK Ca complex to hyperpolarize and relax resistance arteries.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Genetic Ablation of Ca V 3.2 Enhances Arterial Myogenic Tone
Our earlier reports revealed the involvement of Ca V 3.2 channels in negative feedback control of rat cerebral arterial tone 10 ; thus, channel deletion should enhance myogenic tone. Figure 1A Ca V 3.2 −/− arteries were myogenically active and constricted as intravascular pressure increased from 20 to 100 mm Hg. Ca 2+ -free saline (0 mmol/L Ca 2+ +2 mmol/L EGTA) reversed myogenic constriction and evoked passive arterial dilation. Expressing data as a percentage myogenic tone ( Figure 1C ) revealed the predicted enhancement in Ca V 3.2 −/− arteries (at 60 mm Hg: Ca V 3.2 −/− , 28%±2%; C57BL/6, 19%±3%). Although myogenic tone was significantly different, 60 mmol/L K + -induced vasoconstriction was similar in C57BL/6 (40%±2%) and Ca V 3.2 −/− (43%±2%) pressurized arteries ( Figure 1D ). Note, the basal diameter of Ca V 3.2 −/− arteries was smaller than that of C57BL/6, a finding consistent with variable myogenic tone. Interpretational cautious is, however, warranted because Ca V 3.2 −/− mice display a lighter body mass than wildtype animals. 12 Quantitative PCR showed that mRNA expression of Ca V 1.2, Ca V 3.1, BK Ca -α, or RyR2 was comparable in wild-type and Ca V 3.2 −/− arteries ( Figure 1E ).
Micromolar Ni 2+ Selectively Blocks Ca V 3.2 Currents
Mesenteric arterial smooth muscle cells from C57BL/6 mice express 3 subtypes of voltage-gated Ca 2+ channels (Ca V 1.2, Ca V 3.1, and Ca V 3.2), 9 and thus, total inward current is representative of this ensemble of channels. To distinguish between the subcomponents, we used patch clamp electrophysiology in combination with defined pharmacology. 10 First, nifedipine (200 nmol/L) was applied to block L-type Ca V 1.2 channels and reveal a current predominated by T-type conductances (Figure 2A ). Subsequent application of 50 μmol/L Ni 2+ , which is presumed to be a selective Ca V 3.2 blocker, [10] [11] [12] [13] [14] reduced the nifedipine-insensitive T-type currents in C57BL/6 but not in Ca V 3.2 −/− smooth muscle cells ( Figure 2B and 2C). The absence of an effect of Ni 2+ in Ca V 3.2 −/− myocytes is consistent with this pharmacological selectivity. Note that the broad-spectrum T-type blocker (NNC 55-0396, 1 μmol/L) subsequently abolished the residual current 15 in both C57BL/6 and Ca V 3.2 −/− myocytes because of the suppression of remaining Ca V 3.1 current ( Figure 2C ). Importantly, voltage dependence profiles demonstrated that the T-type current is available for activation at physiological membrane potentials ( Figure I in the online-only Data Supplement). As noted previously, Ca V 3.1 mRNA levels were similar among the 2 groups of animals, whereas Ca V 1.2 was modestly but insignificantly lower in Ca V 3.2 −/− arteries ( Figure 1E ).
Ca V 3.2 Activity Regulates BK Ca -Mediated STOCs
Given the enhancement of myogenic constriction in Ca V 3.2 −/− arteries, we next tested whether this T-type channel modifies myogenic reactivity through a negative feedback response that involves downstream BK Ca . 10, 12 We used perforated patch clamp electrophysiology to monitor BK Ca -mediated spontaneous transient outward K + currents (STOCs) in arterial smooth muscle cells from wild-type and knockout animals. In C57BL/6 cells held at the physiological voltage of −40 mV, Ni 2+ significantly suppressed STOC frequency. In contrast, Ni 2+ had no effect on STOCs when C57BL/6 cells were voltage-clamped at more depolarized potentials (−20 mV), a finding consistent with the voltage profile of Ca V 3.2 channel ( Figure 3A ). In Ca V 3.2 −/− cells, Ni 2+ had no effect at either −40 or −20 mV ( Figure 3B ). All STOCs were fully abolished by the application of the BK Ca inhibitor paxilline (1 μmol/L; Figure  II in the online-only Data Supplement). Message expression of the BK Ca pore-forming subunit (BK Ca -α) was similar in C57BL/6 and Ca V 3.2 −/− arteries ( Figure 1E ). Further, Ni 2+ had no effect on STOC amplitude under different experimental conditions ( Figure 3C ). Note, basal STOCs tended to fire at lower frequencies in Ca V 3.2 −/− myocytes compared with C57BL/6 counterparts. Statistical analysis was not performed across groups as cells that did not fire sufficient STOCs were eliminated a priori from experimentation.
Ca V 3.2 Channel Controls Ca 2+ Spark Generation
Given the ability of Ca V 3.2 channel to modulate BK Ca current ( Figure 3 ) and the reported correlation between RyRmediated spark generation and BK Ca activation, 10, 16 we next explored the Ca V 3.2-Ca 2+ spark relationship using Ca 2+ imaging and line scan analysis of mouse mesenteric arteries ( Figure 4 ). In C57BL/6 arteries loaded with Fluo-4, Ca 2+ sparks were observed in 76% of the 454 line scans performed under control conditions. Depolarizing arteries (30 mmol/L K + ) increased spark activity (95%), whereas the subsequent addition of Ni 2+ significantly reduced firing (52%; Figure 4A and 4B). In comparison, 30 mmol/L K + increased spark firing in Ca v 3.2 −/− arteries from 58% to 94% (456 line scans) but Ni 2+ failed to attenuate sparks (98%; Figure 4A and 4B). In depolarized wild-type C57BL/6 arteries, Ca 2+ spark frequency was calculated to be 0.0347 and 0.0153 sparks/μm s in the absence and presence of Ni 2+ , respectively; spark frequency in knockout tissues was distinctively insensitive to the application of Ni 2+ ( Figure 4C ). The genetic absence of Ca V 3.2 channels was notably associated with lower percentage firing (Ca V 3.2 −/− , 58%; C57BL/6, 76%) and lower basal Ca 2+ spark frequency when compared with wild-type arteries (Ca V 3.2 −/− , 0.0065±0.0014; C57BL/6, 0.0169±0.005 sparks/μm s). The amplitudes and spatiotemporal characteristics of Ca 2+ sparks displayed no significant changes before and after the application of Ni 2+ on C57BL/6 and Ca V 3.2 −/− arteries ( Figure 4D ).
Ca V 3.2 Activity Restrains Myogenic Constriction by Altering BK Ca Feedback
The application of Ni 2+ (50 μmol/L) onto C57BL/6 arteries evoked vasoconstriction at intravascular pressure values between 20 and 60 mm Hg, and this vasomotor effect diminished at higher pressures; Ca V 3.2 −/− arteries lacked a similar response ( Figure 5A ). The percentage of myogenic tone in wild-type C57BL/6 arteries increased after the application of Ni 2+ (at 60 mm Hg: control 20%±4% versus Ni 2+ 25%±1%), but was not altered in Ca V 3.2 −/− arteries (control 30%±5% versus Ni 2+ 28%±8%; Figure 5B ). Coinciding with vasomotor data, membrane potential measurements showed that Ni 2+ only depolarized C57BL/6 but not Ca V 3.2 −/− pressurized arteries (60 mm Hg; Figure 5C ). In C57BL/6 arteries, the BK Ca blocker (paxilline, 1 μmol/L) evoked vasoconstriction and enhanced myogenic tone similar to that of Ni 2+ (Figure 5D ), an observation consistent with a common signaling axis between Ca V 3.2 and BK Ca channels. When Ni 2+ and paxilline were sequentially added to the same wild-type artery, Ni 2+ evoked vasoconstriction, whereas subsequent paxilline had no additional effect. Similar experiments using Ca V 3.2 −/− arteries demonstrated a lack of vasomotor responses to Ni 2+ but preserved responsiveness to paxilline ( Figure 5E ).
Ca V 3.2 −/− Mice Display Normal Blood Pressure Responses
Pharmacological and genetic approaches suggested that Ca V 3.2 channel counterbalances myogenic constriction (Figure 1 and 5) and could as such influence blood pressure regulation. To explore this possibility, we catheterized carotid arteries of C57BL/6 and Ca V 3.2 −/− mice to monitor blood pressure under resting conditions and in response to a vasopressor challenge. As depicted ( Figure 6A ), basal mean arterial pressure was similar in wild-type and knockout mice (C57BL/6, 100±2 mm Hg; Ca V 3.2 −/− , 103±5 mm Hg), a finding consistent with earlier reports in conscious animals. 17, 18 Given that Ca V 3.2 channels seem to be involved in a feedback mechanism, we next assessed whether this conductance can alter mean arterial pressure responsiveness to a vasopressor challenge. The intravenous administration of phenylephrine (α 1 -adrenoceptor agonist, 1-16 μg/kg body weight) evoked dose-dependent rises in mean arterial pressure, and these transient responses were similar among the 2 groups ( Figure 6B ). Analogous to in vivo experiments, phenylephrine (0.01-10 μmol/L)-induced vasoconstriction was similar in C57BL/6 and Ca V 3.2 −/− mesenteric arteries ( Figure 6C and 6D ).
Discussion
This study used wild-type and Ca V 3.2 knockout mice to examine the purported contribution of Ca V 3.2 channels to a negative feedback response that counterbalances arterial tone development. Using mesenteric arteries, functional experiments illustrated that the genetic ablation or pharmacological suppression of Ca V 3.2 channel selectively enhanced myogenic constriction. Subsequent electrophysiological recordings revealed that Ca V 3.2 channel modulates downstream BK Camediated STOCs. Ca 2+ imaging further demonstrated that Ca 2+ spark generation is an intermediary step in the Ca V 3.2-BK Ca functional axis. Finally, although Ca V 3.2 moderated myogenic tone, this regulatory mechanism did not influence resting blood pressure or vasopressor-induced responses. In summary, findings from this study establish a model by which Ca V 3.2 channel restrains myogenic constriction by driving a process where Ca 2+ influx triggers Ca 2+ sparks and downstream activation of BK Ca currents ( Figure III in the onlineonly Data Supplement). Resistance arteries control tissue perfusion and respond to a range of vasoactive stimuli. [1] [2] [3] [4] [5] The integral ability of resistance arteries to respond to perturbations in arterial pressure, known as the myogenic response, 6 is intrinsic to vascular smooth muscle and plays an essential role in maintaining blood flow and capillary pressure to tissues, such as the brain and the heart. 19 This response is mechanistically linked to a rise in cytosolic [Ca 2+ ] i driven by a depolarization that activates L-type Ca V 1.2 channels. The traditional perspective that Ca V 1.2 is the only voltage-gated Ca 2+ channel of functional significance 3 has shifted with the identification of 2 T-type Ca 2+ channels, 7,8 the first being Ca V 3.1, which modestly facilitates myogenic tone at hyperpolarized voltages. 9 In contrast, Ca V 3.2 channels have been reported to drive a paradoxical feedback response that limits arterial constriction. 10, 12 The feedback response begins with Ca 2+ influx through Ca V 3.2 channels triggering ryanodine receptors to initiate Ca 2+ sparks. These discrete sarcoplasmic reticulum-driven events in turn activate BK Ca channels to hyperpolarize and dilate resistance arteries. 10 Although an intriguing concept, data interpretation is singularly dependent on the presumed selectivity of Ni 2+ as a pharmacological Ca V 3.2 blocker. 11 Current knowledge is also restricted to the cerebral circulation, and experiments have not extended to other vascular beds essential to blood pressure regulation.
One means to better probe the functional properties of arterial Ca V 3.2 channel is to use an animal model in which the channel has been genetically ablated. 12 In this regard, we performed pressure myography on arteries from Ca V 3.2 knockout (Ca V 3.2 −/− ) mice to study the vascular phenotype. Consistent with the view that Ca V 3.2 channel mediates feedback vasodilation, we observed enhanced myogenic constriction in mesenteric arteries from Ca V 3.2 −/− mice. This finding was somewhat akin to the functional observations in coronary arteries 12 and the enhancement of rat cerebral arterial myogenic tone noted in the presence of Ni 2+ . 10 Our present findings overcome concerns raised by past studies that off-target effects of Ni 2+ could theoretically have accounted for the vasomotor responses. [20] [21] [22] In particular, we were unable to elicit Ni 2+ -sensitive current in Ca V 3.2 −/− arterial myocytes, and Ni 2+ also failed to constrict/ depolarize arteries from knockout mice.
The unexpected ability of Ca V 3.2 channel to mediate a negative feedback response has been previously tied to downstream modulation of BK Ca channels through intermediary activation of ryanodine receptors. 10 In arterial smooth muscle, BK Ca is ubiquitously expressed and known to moderate membrane depolarization and arterial constriction. 23 To activate arterial BK Ca , vasoactive stimuli must induce depolarization and elicit a discrete micromolar rise in [Ca 2+ ] i in the subsarcolemma taking the form of a Ca 2+ spark. 24 Here, we present multiple lines of evidence implicating BK Ca as the final downstream effector of Ca V 3.2 channel. First, electrophysiology revealed that BK Ca -mediated STOCs were sensitive to Ni 2+ in wild-type but not in Ca V 3.2 −/− arterial myocytes. Second, pressure myography illustrated that adding Ni 2+ or paxilline (BK Ca inhibitor) to the superfusate comparably augmented myogenic tone. Intriguingly, applying paxilline to wild-type arteries pretreated with Ni 2+ had no additive effect, consistent with Ca V 3.2 and BK Ca channels being linked through a common sequential pathway.
It has been long established that RyR activation is responsible for the initiation of BK Ca -mediated STOCs in arterial smooth muscle, 16, 24 and this recognized relationship led us to examine the nature of Ca 2+ spark generation in mouse mesenteric arteries. Indeed, inhibitors of RyR (eg, ryanodine) has been shown to suppress the generation of STOCs in vascular smooth muscle irrespective of their origin. 24 Here and in consistency with Ca V 3.2 channel driving Ca 2+ sparks and subsequently STOC generation, we used Ca 2+ imaging and line scan analysis and observed that spark frequency decreased in wild-type arteries when Ca V 3.2 channels were inhibited with Ni 2+ . We also found that firing of Ca 2+ sparks was unaffected by this divalent cation in Ca V 3.2 −/− arteries and that basal Ca 2+ spark frequency was lower than those of wild-type arteries. These findings align well with recent work from the cerebral circulation where a variety of functional, structural, electrophysiological, and computational observations draw a critical relationship between Ca V 3.2 and RyR and then BK Ca ( Figure  III in the online-only Data Supplement). 10 Intriguingly, the preceding work is distinct from neuronal studies where T-type conductances have been suggested to directly activate Ca 2+activated K + channels independent of RyR. [25] [26] [27] [28] With Ca V 3.2 channels playing an intimate role in limiting myogenic constriction, it is logical to argue that the loss of this conductance would alter peripheral resistance and systemic blood pressure regulation. We tested this supposition by catheterizing anesthetized mice and assessing blood pressure at rest and in response to a vasopressor challenge. Resting blood pressure was similar among wild-type and knockout mice, a finding consistent with earlier reports which used different monitoring approaches (eg, catheterization, tail cuff) in conscious animals over longer time spans (days to weeks). 17, 18 Given the presumed role of Ca V 3.2 in feedback (rather than active vasodilation), we challenged blood pressure regulation using intravenous phenylephrine. This multidose challenge evoked comparable rises in blood pressure among the 2 animal groups; likewise, mesenteric arteries isolated from wild-type and Ca V 3.2 −/− mice constricted similarly to this α 1 -adrenergic agonist. These in vivo and in vitro results interestingly seem to rule out a direct modulatory role for vascular Ca V 3.2 channels in agonistinduced vasoconstriction.
It is not clear at present why blood pressure responses fail to change. Perhaps, the loss of smooth muscle feedback in Ca V 3.2 −/− arteries is compensated by enhanced dilatory feedback from the endothelium. Other functional compensation may have occurred in this global knockout independent of vascular smooth muscle 29 ; in this context, establishing a smooth muscle-specific Ca V 3.2 knockout model would be valuable. It should also be recognized that for the proposed Ca V 3.2/RyR/BK Ca feedback mechanism to effectively drive a blood pressure response, it should be ideally present in a full range of vascular beds. Recent work documenting heterogeneity of BK Ca activity, 30 because of differences in channel activity and Ca 2+ spark generation, challenges this key assumption. Further investigation is warranted to address this intriguing anomaly.
In conclusion, this study showed that arterial Ca V 3.2 channels retain a unique ability to counterbalance myogenic constriction. This negative feedback response entails a modulatory paradigm in which Ca 2+ flux through Ca V 3.2 channel triggers Ca 2+ spark generation and then activates BK Ca channels to hyperpolarize and relax arteries ( Figure III in the online-only Data Supplement). This novel functional axis, recently described in the human cerebral circulation, 31 challenges the traditional view that voltage-gated Ca 2+ channels solely facilitate arterial tone development. 
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